Mid-pass whole genome sequencing enables biomedical genetic studies of diverse populations

Abstract Background Historically, geneticists have relied on genotyping arrays and imputation to study human genetic variation. However, an underrepresentation of diverse populations has resulted in arrays that poorly capture global genetic variation, and a lack of reference panels. This has contrib...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anne-Katrin Emde, Amanda Phipps-Green, Murray Cadzow, C. Scott Gallagher, Tanya J. Major, Marilyn E. Merriman, Ruth K. Topless, Riku Takei, Nicola Dalbeth, Rinki Murphy, Lisa K. Stamp, Janak de Zoysa, Philip L. Wilcox, Keolu Fox, Kaja A. Wasik, Tony R. Merriman, Stephane E. Castel
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/295efebb8290477c8a164ca0f7d5bfec
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:295efebb8290477c8a164ca0f7d5bfec
record_format dspace
spelling oai:doaj.org-article:295efebb8290477c8a164ca0f7d5bfec2021-11-08T10:57:36ZMid-pass whole genome sequencing enables biomedical genetic studies of diverse populations10.1186/s12864-021-07949-91471-2164https://doaj.org/article/295efebb8290477c8a164ca0f7d5bfec2021-11-01T00:00:00Zhttps://doi.org/10.1186/s12864-021-07949-9https://doaj.org/toc/1471-2164Abstract Background Historically, geneticists have relied on genotyping arrays and imputation to study human genetic variation. However, an underrepresentation of diverse populations has resulted in arrays that poorly capture global genetic variation, and a lack of reference panels. This has contributed to deepening global health disparities. Whole genome sequencing (WGS) better captures genetic variation but remains prohibitively expensive. Thus, we explored WGS at “mid-pass” 1-7x coverage. Results Here, we developed and benchmarked methods for mid-pass sequencing. When applied to a population without an existing genomic reference panel, 4x mid-pass performed consistently well across ethnicities, with high recall (98%) and precision (97.5%). Conclusion Compared to array data imputed into 1000 Genomes, mid-pass performed better across all metrics and identified novel population-specific variants with potential disease relevance. We hope our work will reduce financial barriers for geneticists from underrepresented populations to characterize their genomes prior to biomedical genetic applications.Anne-Katrin EmdeAmanda Phipps-GreenMurray CadzowC. Scott GallagherTanya J. MajorMarilyn E. MerrimanRuth K. ToplessRiku TakeiNicola DalbethRinki MurphyLisa K. StampJanak de ZoysaPhilip L. WilcoxKeolu FoxKaja A. WasikTony R. MerrimanStephane E. CastelBMCarticleBiotechnologyTP248.13-248.65GeneticsQH426-470ENBMC Genomics, Vol 22, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biotechnology
TP248.13-248.65
Genetics
QH426-470
spellingShingle Biotechnology
TP248.13-248.65
Genetics
QH426-470
Anne-Katrin Emde
Amanda Phipps-Green
Murray Cadzow
C. Scott Gallagher
Tanya J. Major
Marilyn E. Merriman
Ruth K. Topless
Riku Takei
Nicola Dalbeth
Rinki Murphy
Lisa K. Stamp
Janak de Zoysa
Philip L. Wilcox
Keolu Fox
Kaja A. Wasik
Tony R. Merriman
Stephane E. Castel
Mid-pass whole genome sequencing enables biomedical genetic studies of diverse populations
description Abstract Background Historically, geneticists have relied on genotyping arrays and imputation to study human genetic variation. However, an underrepresentation of diverse populations has resulted in arrays that poorly capture global genetic variation, and a lack of reference panels. This has contributed to deepening global health disparities. Whole genome sequencing (WGS) better captures genetic variation but remains prohibitively expensive. Thus, we explored WGS at “mid-pass” 1-7x coverage. Results Here, we developed and benchmarked methods for mid-pass sequencing. When applied to a population without an existing genomic reference panel, 4x mid-pass performed consistently well across ethnicities, with high recall (98%) and precision (97.5%). Conclusion Compared to array data imputed into 1000 Genomes, mid-pass performed better across all metrics and identified novel population-specific variants with potential disease relevance. We hope our work will reduce financial barriers for geneticists from underrepresented populations to characterize their genomes prior to biomedical genetic applications.
format article
author Anne-Katrin Emde
Amanda Phipps-Green
Murray Cadzow
C. Scott Gallagher
Tanya J. Major
Marilyn E. Merriman
Ruth K. Topless
Riku Takei
Nicola Dalbeth
Rinki Murphy
Lisa K. Stamp
Janak de Zoysa
Philip L. Wilcox
Keolu Fox
Kaja A. Wasik
Tony R. Merriman
Stephane E. Castel
author_facet Anne-Katrin Emde
Amanda Phipps-Green
Murray Cadzow
C. Scott Gallagher
Tanya J. Major
Marilyn E. Merriman
Ruth K. Topless
Riku Takei
Nicola Dalbeth
Rinki Murphy
Lisa K. Stamp
Janak de Zoysa
Philip L. Wilcox
Keolu Fox
Kaja A. Wasik
Tony R. Merriman
Stephane E. Castel
author_sort Anne-Katrin Emde
title Mid-pass whole genome sequencing enables biomedical genetic studies of diverse populations
title_short Mid-pass whole genome sequencing enables biomedical genetic studies of diverse populations
title_full Mid-pass whole genome sequencing enables biomedical genetic studies of diverse populations
title_fullStr Mid-pass whole genome sequencing enables biomedical genetic studies of diverse populations
title_full_unstemmed Mid-pass whole genome sequencing enables biomedical genetic studies of diverse populations
title_sort mid-pass whole genome sequencing enables biomedical genetic studies of diverse populations
publisher BMC
publishDate 2021
url https://doaj.org/article/295efebb8290477c8a164ca0f7d5bfec
work_keys_str_mv AT annekatrinemde midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT amandaphippsgreen midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT murraycadzow midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT cscottgallagher midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT tanyajmajor midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT marilynemerriman midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT ruthktopless midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT rikutakei midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT nicoladalbeth midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT rinkimurphy midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT lisakstamp midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT janakdezoysa midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT philiplwilcox midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT keolufox midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT kajaawasik midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT tonyrmerriman midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
AT stephaneecastel midpasswholegenomesequencingenablesbiomedicalgeneticstudiesofdiversepopulations
_version_ 1718442406966198272